Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 3
2009 3
2013 5
2014 4
2015 3
2016 1
2018 4
2019 9
2020 6
2021 8
2022 4
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean shuzo mori[Author] (2 results)?
Early laparoscopic cholecystectomy for acute cholecystitis following the Tokyo Guidelines 2018: a prospective single-center study of 201 consecutive cases.
Mishima K, Fujiyama Y, Wakabayashi T, Igarashi K, Ozaki T, Honda M, Mori S, Funamizu N, Tsutsui A, Okamoto N, Marescaux J, Wakabayashi G. Mishima K, et al. Among authors: mori s. Surg Endosc. 2023 Aug;37(8):6051-6061. doi: 10.1007/s00464-023-10094-x. Epub 2023 Apr 28. Surg Endosc. 2023. PMID: 37118031
Clinical influence of prophylactic lateral lymph node dissection on oncologic outcomes of patients with mid-low rectal cancer undergoing mesorectal excision: a meta-analysis.
Ishizuka M, Shibuya N, Hachiya H, Nishi Y, Takayanagi M, Fujita J, Ihara K, Shiraki T, Matsumoto T, Mori S, Iso Y, Nakamura T, Aoki T, Irisawa A. Ishizuka M, et al. Among authors: mori s. J Gastrointest Surg. 2024 Apr;28(4):548-558. doi: 10.1016/j.gassur.2024.01.014. Epub 2024 Jan 23. J Gastrointest Surg. 2024. PMID: 38583909 Review.
N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur-uracil/leucovorin.
Miyashita S, Shimizu T, Ishizuka M, Niki M, Nishi Y, Shibuya N, Hachiya H, Matsumoto T, Sakuraoka Y, Shiraki T, Mori S, Iso Y, Irisawa A, Aoki T. Miyashita S, et al. Among authors: mori s. Anticancer Res. 2023 May;43(5):2219-2225. doi: 10.21873/anticanres.16385. Anticancer Res. 2023. PMID: 37097679
59 results